IBM Life Sciences
Division of International Business Machines (IBM) Corp.
Latest From IBM Life Sciences
DSCSA Pilot Explores Feasibility Of Food Blockchain Program For Pharmaceutical Track-And-Trace Compliance
Safe lettuce to safe pills? Participants in a US FDA pilot program are seeing if a food tracking blockchain program can also be used to track pharmaceuticals under a DSCSA pilot program now underway; KPMG officials touts data security as one of the main advantages of blockchain.
Sanofi says the virtual innovation lab it will create with Google will enable precision health care and optimize R&D and commercial operations. Incoming CEO Hudson has been tasked with improving the pharma’s R&D and digital capabilities.
Real world data and machine learning could play an increasingly important role in decision-making processes in diabetes care according to new research by Roche and IBM. The two companies conducted a major study to predict diabetes-related kidney disease in patients with chronic disease.
The past year saw US FDA and industry work hard and fast to prepare for what looks like an inevitable boom in the digital-health sector. According to interviews, the time is ripe for adoption of mobile health apps to help reduce health-care costs, but the brave new world also brings with it big challenges.
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- International Business Machines (IBM) Corp.
- Senior Management
Louis V Gerstner, Chmn. & CEO
Samuel J Palmisano, Pres. & COO
- Contact Info
IBM Life Sciences
Phone: (914) 288-3000
IBM Corp., 1133 Westchester Ave.
White Plains, NY 10604
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.